Comprehensive Consideration before the Decision-Making of the Systemic Treatment in Patients with Advanced Hepatocellular Carcinoma.
作者信息
Chen Mingyu, Hu Jiahao, Cao Jiasheng, Cai Xiujun
机构信息
Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University, Hangzhou, China.
出版信息
Liver Cancer. 2020 Apr;9(2):221-222. doi: 10.1159/000502775. Epub 2019 Oct 16.
Abstract
摘要
相似文献
1
Comprehensive Consideration before the Decision-Making of the Systemic Treatment in Patients with Advanced Hepatocellular Carcinoma.晚期肝细胞癌患者全身治疗决策前的综合考量
Liver Cancer. 2020 Apr;9(2):221-222. doi: 10.1159/000502775. Epub 2019 Oct 16.
2
Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma.索拉非尼与立体定向体部放疗治疗不可切除的晚期肝细胞癌的成本效益
Radiat Oncol. 2016 May 18;11:69. doi: 10.1186/s13014-016-0644-4.
3
Contrasting Some Differences in Managing Advanced Unresectable Hepatocellular Carcinoma Between the East and the West.对比东西方在治疗不可切除的晚期肝细胞癌方面的差异。
Clin Oncol (R Coll Radiol). 2019 Aug;31(8):560-569. doi: 10.1016/j.clon.2019.06.002.
4
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma.晚期肝细胞癌系统治疗的药物遗传学。
World J Gastroenterol. 2019 Aug 7;25(29):3870-3896. doi: 10.3748/wjg.v25.i29.3870.
5
Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review.肝细胞癌立体定向体部放射治疗（SBRT）的卫生经济学评价：一项系统评价
Cost Eff Resour Alloc. 2020 Jan 10;18:1. doi: 10.1186/s12962-019-0198-z. eCollection 2020.
6
Patterns and challenges of treatment sequencing in patients with hepatocellular carcinoma: Experience from a German referral center.肝细胞癌患者治疗顺序的模式与挑战：来自德国一家转诊中心的经验
J Gastroenterol Hepatol. 2017 Oct;32(10):1730-1738. doi: 10.1111/jgh.13761.
7
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.钇-90微球放射性栓塞治疗不可切除的肝细胞癌
Cochrane Database Syst Rev. 2016 Feb 16;2:CD011313. doi: 10.1002/14651858.CD011313.pub2.
8
Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision Analysis.优化晚期肝细胞癌的序贯系统治疗：一项决策分析
Cancers (Basel). 2020 Jul 31;12(8):2132. doi: 10.3390/cancers12082132.
9
Well-differentiated hepatocellular nodule: Making a diagnosis on biopsy and resection specimens of patients with advanced stage chronic liver disease.高分化肝细胞结节：对晚期慢性肝病患者的活检和切除标本进行诊断
Semin Diagn Pathol. 2017 Mar;34(2):138-145. doi: 10.1053/j.semdp.2016.12.009. Epub 2016 Dec 20.
10
[Hepatocellular carcinoma].[肝细胞癌]
Gan To Kagaku Ryoho. 2010 Jul;37(7):1219-23.
引用本文的文献
1
Response to the Comments on Rimassa et al.: "Systemic Treatment Options in Hepatocellular Carcinoma".对里马萨等人《肝细胞癌的全身治疗选择》评论的回应
Liver Cancer. 2020 Apr;9(2):223-224. doi: 10.1159/000503302. Epub 2019 Oct 22.
2
Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma.术后经导管动脉化疗栓塞辅助治疗对肝癌切除术后患者获益的预后因素和预测因素。
World J Gastroenterol. 2020 Mar 14;26(10):1042-1055. doi: 10.3748/wjg.v26.i10.1042.
本文引用的文献
1
Systemic Treatment Options in Hepatocellular Carcinoma.肝细胞癌的全身治疗选择
Liver Cancer. 2019 Nov;8(6):427-446. doi: 10.1159/000499765. Epub 2019 May 29.
2
Current Treatment Landscape for Advanced Hepatocellular Carcinoma: Patient Outcomes and the Impact on Quality of Life.晚期肝细胞癌的当前治疗格局：患者预后及对生活质量的影响
Cancers (Basel). 2019 Jun 18;11(6):841. doi: 10.3390/cancers11060841.
3
Systemic Therapy for Hepatocellular Carcinoma: 2017 Update.肝细胞癌的全身治疗：2017年更新
Oncology. 2017;93 Suppl 1:135-146. doi: 10.1159/000481244. Epub 2017 Dec 20.
4
Progress in systemic therapy of advanced hepatocellular carcinoma.晚期肝细胞癌全身治疗的进展
World J Gastroenterol. 2016 Aug 7;22(29):6582-94. doi: 10.3748/wjg.v22.i29.6582.
5
Systemic cytotoxic chemotherapy of patients with advanced hepatocellular carcinoma in the era of sorafenib nonavailability.索拉非尼不可及时代晚期肝细胞癌患者的全身细胞毒性化疗。
J Clin Gastroenterol. 2014 Mar;48(3):e22-9. doi: 10.1097/MCG.0b013e3182a54ec8.
Zotero 插件